Australia
Emerald Clinics hits record number of patients; joins global fight against COVID-19
Emerald Clinics Ltd (ASX:EMD) continued to make progress against its IPO goals, finishing its June 2020 quarter with record appointment volumes and the expansion of its Real World Evidence technology platform beyond cannabinoids.
The healthcare technology and services company has also joined in the global fight against the COVID-19 pandemic, taking the lead as program manager for the development of a National Clinical Data and Analytical Platform (CDAP) of COVID-19 patient cases to collect clinical data from confirmed COVID-19 patients, from a variety of sources, in close to real-time.
Emerald Clinics chief executive officer Michael Winlo said: “Our strong end to 2020 is pleasing, given the challenges posed by COVID-19 to both patients and our clients. We continue to make progress against our IPO goals, see increasing numbers of patients and new referrals each month and also invest in new and innovative patient monitoring technologies, that both assists patients and increases the val..
-
Tech7 months ago
Search engine startup asks users to be the customer, not the product
-
Europe4 weeks ago
Covid: Flights shut down as EU discusses UK virus threat
-
Health4 weeks ago
Spain ‘to register’ those who refuse to have Covid-19 vaccine
-
Sports4 years ago
Boxing continues to knock itself out with bewildering, incorrect decisions
-
Sports4 years ago
Phillies’ Aaron Altherr makes mind-boggling barehanded play
-
Europe2 months ago
45 arrested across Europe and Brazil as authorities seize ‘record haul’ of cocaine
-
latest news7 months ago
Creepy technologies invade European post-pandemic workplaces
-
Sports4 years ago
Steph Curry finally got the contract he deserves from the Warriors